Bumps and bridges on the road to responsible sharing of clinical trial data

Clinical Trials

Volumn 11, Issue 1, 2014, Pages 7-12

  Berlin, Jesse A ^a   Morris, Sandra ^a   Rockhold, Frank ^b   Askie, Lisa ^c   Ghersi, Davina ^d   Waldstreicher, Joanne ^a  

^a JOHNSON AND JOHNSON   (United States)

^b GLAXOSMITHKLINE   (United States)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; CLINICAL TRIALS AS TOPIC; CONFIDENTIALITY; CONSENSUS; COOPERATIVE BEHAVIOR; HUMANS; INFORMATION DISSEMINATION; META-ANALYSIS AS TOPIC; SOCIAL RESPONSIBILITY;

EID: 84893980202     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1177/1740774513514497     Document Type: Article

References (19)

1. PhRMA. Principles for responsible clinical trial data sharing, 2013. Available at: http://phrma.org/sites/default/files/pdf/ PhRMAPrinciplesForResponsibleClinicalTrialDataSharing.pdf (accessed 5 November 2013).
2. Nisen P, Rockhold F. Access to patient-level data from GlaxoSmithKline clinical trials. N Engl J Med. 2013 ; 369 (5). 475-78
3. Yale School of Medicine. YODA Project, 2013. Available at: http://medicine.yale.edu/core/projects/yodap/index.aspx (accessed 5 November 2013).
4. Institute of Medicine. Strategies for responsible sharing of clinical trial data, 2013. Available at: http://www.iom.edu/Activities/Research/ SharingClinicalTrialData.aspx (accessed 5 November 2013).
5. Hawkes N. Industry and drug regulators disagree on which data should remain confidential. BMJ. 2013 ; 347: f5390
6. Gøtzsche PC. Why we need easy access to all data from all clinical trials and how to accomplish it. Trials. 2011 ; 12: 249
7. Doshi P, Jefferson T, Del Mar C. The imperative to share clinical study reports: Recommendations from the Tamiflu experience. PLoS Med. 2012 ; 9 (4). e1001201
8. Vallance P, Chalmers I. Secure use of individual patient data from clinical trials. Lancet. 2013 ; 382 (9898). 1073-74
9. Eichler HG, Abadie E, Breckenridge A, et al. Open clinical trial data for all? A view from regulators. PLoS Med. 2012 ; 9 (4). e1001202
10. Yahav D, Paul M, Fraser A, et al. Efficacy and safety of cefepime: A systematic review and meta-analysis. Lancet Infect Dis. 2007 ; 7 (5). 338-48
11. Kim PW, Wu YT, Cooper C, et al. Meta-analysis of a possible signal of increased mortality associated with cefepime use. Clin Infect Dis. 2010 ; 51 (4). 381-89
12. Sipahi I, Debanne SM, Rowland DY, et al. Angiotensin-receptor blockade and risk of cancer: Meta-analysis of randomised controlled trials. Lancet Oncol. 2010 ; 11 (7). 627-36
13. European Medicines Agency. Questions and answers on the review of angiotensin II receptor antagonists and the risk of cancer, 2011. Available at: http://www.ema.europa.eu/docs/en-GB/document-library/Medicine-QA/2011/10/ WC500116862.pdf (accessed 5 November 2013).
14. Systematic Reviews. PROSPERO at one year: An evaluation of its utility, 2013. Available at: http://www.systematicreviewsjournal.com/content/2/1/4 (accessed 5 November 2013).
15. National Institutes of Health. Grants & funding peer review process, 2013. Available at: http://grants.nih.gov/grants/peer-review-process.htm (accessed 5 November 2013).
16. Goldacre B. Are clinical trial data shared sufficiently today? No. BMJ. 2013 ; 347: f1880
17. Sharing Clinical Research Data: Workshop Summary. Washington, DC: The National Academies Press ; 2013: 25 43-26 56.
18. Leaders Engaged on Alzheimer's Disease. Critical Path Institute (C-Path) and the Coalition Against Major Diseases (CAMD), 2013. Available at: http://www.leadcoalition.org/who-we-are/our-members/critical-path-institute/ (accessed 5 November 2013).
19. Cancer Discovery. Data sphere shares clinical trial information, 2012. Available at: http://cancerdiscovery.aacrjournals.org/content/2/12/1072.full (accessed 5 November 2013).